Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT Study of prolonged Tardyferon treatment in women with iron deficiency anemia
2006-003378-90Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Tardyferon with Placebo (2 arms). Primary endpoints: Hemoglobin normalization and iron store repletion at 24 weeks, Serum ferritin response at 24 weeks and 1 more. Started Mar 2007; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2006-003378-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003378-90.